201 related articles for article (PubMed ID: 16850311)
1. Caveolin-1 in meningiomas: expression and clinico-pathological correlations.
Barresi V; Cerasoli S; Paioli G; Vitarelli E; Giuffrè G; Guiducci G; Tuccari G; Barresi G
Acta Neuropathol; 2006 Nov; 112(5):617-26. PubMed ID: 16850311
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
3. Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas.
Barresi V; Cerasoli S; Tuccari G
Neuropathology; 2008 Oct; 28(5):472-8. PubMed ID: 18282163
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of Ki-67/MIB-1 proliferation index in meningiomas.
Torp SH; Lindboe CF; Grønberg BH; Lydersen S; Sundstrøm S
Clin Neuropathol; 2005; 24(4):170-4. PubMed ID: 16033133
[TBL] [Abstract][Full Text] [Related]
5. Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study.
Pistolesi S; Boldrini L; Gisfredi S; De Ieso K; Camacci T; Caniglia M; Lupi G; Leocata P; Basolo F; Pingitore R; Parenti G; Fontanini G
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):118-25. PubMed ID: 15043709
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of HER2 expression in meningiomas: an immunohistochemical and fluorescence in situ hybridization study.
Loussouarn D; Brunon J; Avet-Loiseau H; Campone M; Mosnier JF
Hum Pathol; 2006 Apr; 37(4):415-21. PubMed ID: 16564915
[TBL] [Abstract][Full Text] [Related]
7. Proliferation and progesterone receptor status in benign meningiomas are not age dependent.
Roser F; Nakamura M; Ritz R; Bellinzona M; Dietz K; Samii M; Tatagiba MS
Cancer; 2005 Aug; 104(3):598-601. PubMed ID: 15952201
[TBL] [Abstract][Full Text] [Related]
8. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
9. Does protein expression predict recurrence of benign World Health Organization grade I meningioma?
Kärjä V; Sandell PJ; Kauppinen T; Alafuzoff I
Hum Pathol; 2010 Feb; 41(2):199-207. PubMed ID: 19801161
[TBL] [Abstract][Full Text] [Related]
10. Expression of beta1 and beta4 integrins in normal arachnoid membrane and meningiomas.
Beschet I; Brunon J; Scoazec JY; Mosnier JF
Cancer; 1999 Dec; 86(12):2649-58. PubMed ID: 10594860
[TBL] [Abstract][Full Text] [Related]
11. Cell-adhesion molecules in human meningiomas: correlation with clinical and morphological data.
Figarella-Branger D; Roche PH; Daniel L; Dufour H; Bianco N; Pellissier JF
Neuropathol Appl Neurobiol; 1997 Apr; 23(2):113-22. PubMed ID: 9160896
[TBL] [Abstract][Full Text] [Related]
12. [Expression of integrin-alpha 3 mRNA in meningiomas and its biological significance].
Chen J; Xu XP
Ai Zheng; 2002 May; 21(5):526-9. PubMed ID: 12452046
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment.
Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H
Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521
[TBL] [Abstract][Full Text] [Related]
14. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
15. S100A5: a marker of recurrence in WHO grade I meningiomas.
Hancq S; Salmon I; Brotchi J; De Witte O; Gabius HJ; Heizmann CW; Kiss R; Decaestecker C
Neuropathol Appl Neurobiol; 2004 Apr; 30(2):178-87. PubMed ID: 15043715
[TBL] [Abstract][Full Text] [Related]
16. Detection of progesterone receptor and the correlation with Ki-67 labeling index in meningiomas.
Mukherjee S; Ghosh SN; Chatterjee U; Chatterjee S
Neurol India; 2011; 59(6):817-22. PubMed ID: 22234191
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin-releasing hormone (GnRH) and its receptor in human meningiomas.
Hirota Y; Tachibana O; Uchiyama N; Hayashi Y; Nakada M; Kita D; Watanabe T; Higashi R; Hamada J; Hayashi Y
Clin Neurol Neurosurg; 2009 Feb; 111(2):127-33. PubMed ID: 18980792
[TBL] [Abstract][Full Text] [Related]
18. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
Rushing EJ; Olsen C; Man YG
Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
[TBL] [Abstract][Full Text] [Related]
19. PCNA, Ki-67 and hTERT in residual benign meningiomas.
Maes L; Kalala JP; Cornelissen M; De Ridder L
In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and proliferative potentials in meningiomas.
Debiec-Rychter M; Biernat W; Limon J; Kordek R; Izycka E; Borowska-Lehman J; Imieliński B; Liberski PP
Pol J Pathol; 1999; 50(4):243-8. PubMed ID: 10721264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
